<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>News on endoscout</title>
    <link>https://endoscout.github.io/news/</link>
    <description>Recent content in News on endoscout</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>de-de</language>
    <lastBuildDate>Sat, 13 Apr 2019 10:57:26 +0200</lastBuildDate>
    
	<atom:link href="https://endoscout.github.io/news/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title></title>
      <link>https://endoscout.github.io/news/risk-of-death-following-application/</link>
      <pubDate>Sat, 13 Apr 2019 10:57:26 +0200</pubDate>
      
      <guid>https://endoscout.github.io/news/risk-of-death-following-application/</guid>
      <description>Alvimedica NiTiDES @ CIRSE 2018 NiTiDES is a polymer free stent-eluting the amphilimus formulation (a combination of sirolimus and fatty acid) through the “Abluminal Reservoir Technology” aiming at obtaining the highest efficacy profile for the patient. The polymer-free platform, which is made of nitinol, is integrally covered by the Bio Inducer Surface coating, a second generation pure carbon “ultra thin” layer that drastically increases haemo- and biocompatibility.

Alvimedica NiTiDES – Platform characteristics / Dr.</description>
    </item>
    
    <item>
      <title></title>
      <link>https://endoscout.github.io/news/meta-analysis-observes-increased-mortality/</link>
      <pubDate>Sat, 13 Apr 2019 10:52:30 +0200</pubDate>
      
      <guid>https://endoscout.github.io/news/meta-analysis-observes-increased-mortality/</guid>
      <description>EFFPAC RCT 12-month outstanding results with Luminor DCB have been revealed at CX Symposium 2018 London, April 25th, 2018 – EFFPAC RCT 12-month outstanding results with Luminor DCB have been revealed at CX Symposium 2018.
The 12-month results from the full clinical cohort of the EFFPAC randomized controlled trial (RCT), were presented for the first time at CX Symposium 2018 at the DCB session on April 24th.
Main objective was to assess the effectiveness of Luminor drug coated balloon (DCB) vs.</description>
    </item>
    
  </channel>
</rss>